Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




InterMune Lung Disease Medicine on Fast Track
Link ID 5905
Title InterMune Lung Disease Medicine on Fast Track
Url http://www.medscape.com/viewarticle/574759?src=rss
Description Biotechnology company InterMune Inc on Monday said U.S. regulators granted fast-track status for the development of pirfenidone to treat idiopathic pulmonary fibrosis (IPF), a deadly lung disease. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date May 21, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Two Lots of Noven, Shire ADHD Patch Recalled
  Noven Pharmaceuticals Inc said on Monday that its marketing partner, Shire Ltd, is voluntarily recalling two batches of its skin patch to treat attention-deficit/hyperactivity disorder, because of difficulties removing the release liner when the patch is peeled open. Reuters Health Information
Category:   Articles > Business of Medicine


2. Cost Sharing Deters Mammography, Putting Women at Risk, Study Finds
  Even small copayments led to significantly lower mammography rates among women who, according to clinical guidelines, should undergo screening. Medscape Medical News
Category:   Articles > Business of Medicine


3. International Bodies Call for G8 Action on Health
  Leaders of the Group of Eight (G8) rich nations meeting in Japan next month must tackle health scourges in developing countries to boost global prosperity and security, eight international organisations said on Monday. Reuters Health Information
Category:   Articles > Business of Medicine


4. Using Population-based Routine Data for Evidence-based Health Policy Decisions: Lessons From Three E
  Three case studies, in national health policy from three countries: USA (prescription drug safety), Australia (childhood immunization) and UK (hospital waiting times) are presented.
Journal of Public Health
Category:   Articles > Business of Medicine


5. APP Raising Heparin Prices Amid Higher Costs
  APP Pharmaceuticals Inc, the main supplier of the blood thinner heparin to the U.S. market in the wake of a contamination scandal, said on Thursday it was raising prices because of higher costs for raw materials, additional testing and labor. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS